Potential Role for CAR T-Cell Therapy in MM at Early Relapse
Krina Patel, MD, reviews data from the CARTITUDE-4 and KarMMa-3 studies and shares perspectives on a potential role for CAR T-cell therapy at early relapse.
Source: onclive.com
Early Relapse News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Early Relapse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Early Relapse Today - Breaking & Trending Today
Treatment of Multiple Myeloma at Early Relapse
A panel of expert hematologic-oncologists offer insights on how they treat patients with multiple myeloma at early relapse.
Source: onclive.com
Patient-Reported Outcomes from the CARTITUDE-4 Study Showed Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Multiple Myeloma Symptoms Following Treatment with CARVYKTI® (ciltacabtagene autoleucel)
SOMERSET, N.J.--(BUSINESS WIRE)--Dec 11, 2023--
Source: eagletribune.com
Patient Scenario 2: A 53-Year-Old Man With Relapsed/Refractory FL
Centering discussion on a second patient scenario of follicular lymphoma, key opinion leaders consider best therapy for patients with early or aggressive relapse.
Source: onclive.com
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Clinical Utility and Benefit of clonoSEQ MRD Testing in Blood Cancer Patients at 2022 ASH Annual Meeting
05.12.2022 - SEATTLE, Dec. 05, 2022 (GLOBE NEWSWIRE) - Adaptive Biotechnologies Corporation (Nasdaq: ADPT), together with its collaborators, will present data from more than 30 abstracts showcasing the benefit of Adaptive’s next-generation sequencing ...
Source: wallstreet-online.de